Loading…

Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation

OBJECTIVE:To report on a Caucasian patient who developed steroid-responsive transverse myelitis, graft vs host disease of the gut, and anti-GluRδ2 after allogenic stem cell transplantation. METHODS:Histoimmunoprecipitation (HIP) with the patientʼs serum and cryosections of rat and porcine cerebellum...

Full description

Saved in:
Bibliographic Details
Published in:Neurology : neuroimmunology & neuroinflammation 2016-08, Vol.3 (4), p.e255-e255
Main Authors: Miske, Ramona, Hahn, Stefanie, Rosenkranz, Thorsten, Müller, Matthias, Dettmann, Inga M, Mindorf, Swantje, Denno, Yvonne, Brakopp, Stefanie, Scharf, Madeleine, Teegen, Bianca, Probst, Christian, Melzer, Nico, Meinck, Hans-Michael, Terborg, Christoph, Stöcker, Winfried, Komorowski, Lars
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVE:To report on a Caucasian patient who developed steroid-responsive transverse myelitis, graft vs host disease of the gut, and anti-GluRδ2 after allogenic stem cell transplantation. METHODS:Histoimmunoprecipitation (HIP) with the patientʼs serum and cryosections of rat and porcine cerebellum followed by mass spectrometry was used to identify the autoantigen. Correct identification was verified by indirect immunofluorescence using recombinant GluRδ2 expressed in HEK293 cells. RESULTS:The patientʼs serum produced a granular staining of the cerebellar molecular layer (immunoglobulin G1 and immunoglobulin G3; endpoint titer1:1,000) but did not react with other CNS tissues or 28 established recombinant neural autoantigens. HIP revealed a unique protein band at ∼110 kDa that was identified as GluRδ2. The patientʼs serum also stained GluRδ2 transfected but not mock-transfected HEK293 cells. Control sera from 38 patients with multiple sclerosis, 85 patients with other neural autoantibodies, and 205 healthy blood donors were negative for anti-GluRδ2. Preadsorption with lysate from HEK293-GluRδ2 neutralized the patientʼs tissue reaction whereas control lysate had no effect. In addition to anti-GluRδ2, the patientʼs serum contained immunoglobulin G autoantibodies against the pancreatic glycoprotein CUZD1, which are known to be markers of Crohn disease. CONCLUSIONS:In the present case, the development of anti-GluRδ2 was associated with transverse myelitis, which was supposedly triggered by the stem cell transplantation. Similar to encephalitis in conjunction with anti-GluRδ2 reported in a few Japanese patients, the patientʼs neurologic symptoms ameliorated after steroid therapy.
ISSN:2332-7812
2332-7812
DOI:10.1212/NXI.0000000000000255